Exosomal miR-302b as a novel strategy for reversing cellular senescence and promoting healthy aging
The study by Bi et al. (2025) presents "Senoreverse", an innovative strategy that utilizes exosomal miR-302b to restore the proliferative capacity of senescent cells (SnCs), thus extending lifespan and enhancing cognitive and physical function in aging mice without the risk of tumorigenici...
| Autor: | |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | INCLIVA |
| Repositorio: | r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA |
| OAI Identifier: | oai:incliva.fundanetsuite.com:p19922 |
| Acceso en línea: | https://incliva.portalinvestigacion.com/publicaciones/19922 |
| Access Level: | acceso abierto |
| Palabra clave: | Senescence reversal miR-302b therapy aging regeneration |
| Sumario: | The study by Bi et al. (2025) presents "Senoreverse", an innovative strategy that utilizes exosomal miR-302b to restore the proliferative capacity of senescent cells (SnCs), thus extending lifespan and enhancing cognitive and physical function in aging mice without the risk of tumorigenicity. |
|---|